Funding & investments

Home » Funding & investments

Synthorx Reports Second Quarter Financial Results

SAN DIEGO, Aug. 01, 2019 (GLOBE NEWSWIRE) — Synthorx, Inc. (Nasdaq: THOR), a clinical-stage biotechnology company developing optimized therapeutics for cancer and autoimmune disorders, today reported financial...